SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF A SERIES OF IMIDAZO[1,5-B]PYRIDAZINES

被引:86
作者
LIVERMORE, DGH
BETHELL, RC
CAMMACK, N
HANCOCK, AP
HANN, MM
GREEN, DVS
LAMONT, RB
NOBLE, SA
ORR, DC
PAYNE, JJ
RAMSAY, MVJ
SHINGLER, AH
SMITH, C
STORER, R
WILLIAMSON, C
WILLSON, T
机构
[1] GLAXO GRP RES LTD,DEPT VIROL,GREENFORD,MIDDX,ENGLAND
[2] GLAXO GRP RES LTD,COMPUTAT CHEM GRP,GREENFORD,MIDDX,ENGLAND
关键词
D O I
10.1021/jm00076a005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of substituted imidazo[1,5-b]pyridazines have been prepared and tested for inhibitory activity against the reverse transcriptase of HIV-1 (RT) and their ability to inhibit the growth of infected MT-4 cells. Crystal data are reported on two compounds, 15c and 33. From the structure-activity relationships developed within this and other series, it is proposed that key features of the interaction with RT include hydrogen-bond acceptor and aromatic pi-orbital bonding with the imidazopyridazine nucleus and a benzoyl function separated from the heterocycle by a suitable spacer group. Exceptional activity against the reverse transcriptase of HIV-1 (IC50 = 0.65 nM) was obtained with a 2-imidazolyl-substituted derivative, 7-[2-(1H-imidazol-1-yl)-5-methylimidazo-[1,5-b]pyridazin-7-yl]-1-phenyl-1-heptanone (33) which is attributed to additional binding of the imidazole sp(2) nitrogen atom. A number of the compounds in this series also inhibit the replication of HIV-1 in vitro in MT-4 and C8166 cells at levels observed with the nucleoside AZT.
引用
收藏
页码:3784 / 3794
页数:11
相关论文
共 34 条
[1]   POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY 5-ETHYL-6-PHENYLTHIOURACIL DERIVATIVES THROUGH THEIR INTERACTION WITH THE HIV-1 REVERSE-TRANSCRIPTASE [J].
BABA, M ;
DECLERCQ, E ;
TANAKA, H ;
UBASAWA, M ;
TAKASHIMA, H ;
SEKIYA, K ;
NITTA, I ;
UMEZU, K ;
NAKASHIMA, H ;
MORI, S ;
SHIGETA, S ;
WALKER, RT ;
MIYASAKA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2356-2360
[2]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[3]  
CLARKE RW, 1978, Patent No. 2804909
[4]  
CLARKE RW, 1981, Patent No. 1583911
[5]   SOME OBSERVATIONS ON THE DAKIN-WEST REACTION [J].
CLELAND, GH ;
NIEMANN, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1949, 71 (03) :841-843
[6]   (-)-2'-DEOXY-3'-THIACYTIDINE IS A POTENT, HIGHLY SELECTIVE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 REPLICATION INVITRO [J].
COATES, JAV ;
CAMMACK, N ;
JENKINSON, HJ ;
JOWETT, AJ ;
JOWETT, MI ;
PEARSON, BA ;
PENN, CR ;
ROUSE, PL ;
VINER, KC ;
CAMERON, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :733-739
[7]  
COHEN KA, 1991, J BIOL CHEM, V266, P14674
[8]   IDENTIFICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE RESIDUES THAT CONTRIBUTE TO THE ACTIVITY OF DIVERSE NONNUCLEOSIDE INHIBITORS [J].
CONDRA, JH ;
EMINI, EA ;
GOTLIB, L ;
GRAHAM, DJ ;
SCHLABACH, AJ ;
WOLFGANG, JA ;
COLONNO, RJ ;
SARDANA, VV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1441-1446
[9]  
Dakin HD, 1928, J BIOL CHEM, V78, P91
[10]  
Dakin HD, 1928, J BIOL CHEM, V78, P745